Company
LON:IXI
IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.
263 stories · page 10 of 14
In common with some other companies, IXICO has decided it has way too many shareholders on the register with negligible shareholdings. It plans to offer them a way to offload those shares without incurring dealing costs.
The UK blue-chip index finished up over 72 points at 7,504, while the mid-cap FTSE 250 was also higher
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Thursday
The AIM-listed data science company said the change order extended the contract from an end date of September 2020 to May 2021, as well as the addition of new clinical sites
In the currency markets, the pound is down 30% against the US dollar, while the pound is up 0.26% against the Euro..
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The AIM-listed neuroscience data company said that reported revenue for the full year is expected to be at least £5.1mln, a 24% increase on the previous year
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's big share price movements, including Mincon Group, TomCo, Chemring, Echo Energy, Paddy Power, BAE Systems, Ocean Wilsons and Fusion Antibodies
The AIM-listed data science firm said the additional services provided from the expansion would increase the contract's value by £600,000 to £1.6mln
The UK benchmark of leading shares closed down over 24 points at 7,642.
Some of the main news-driven risers and fallers in London on Tuesday afternoon...
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The company is on track to meet market expectations, which means revenues are likely to grow by double digits
With the Trump-Kim meeting and various pieces of economic data behind us, all eyes are turning to Parliament, which is set to vote on amendments to the EU Withdrawal Bill today and tomorrow
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Wednesday afternoon ...
In the first half of its fiscal year, IXICO secured three new contracts which, along with the other wins last year, helped revenues to climb 30% to £2.9mln
